N-Methyl-2C-I
pharmaceutical compound
N-Methyl-2C-I, also known as 25I-NMe or as N-methyl-4-iodo-2,5-dimethoxyphenethylamine, is a serotonin receptor modulator of the phenethylamine and 2C families related to the psychedelic drug 2C-I. It is specifically the N-methyl analogue of 2C-I.
The drug shows more than 2,500-fold reduced affinity for the serotonin 5-HT2A receptor compared to 2C-I. In addition, N-methyl-2C-I showed around 170-fold lower affinity for the serotonin 5-HT2C receptor relative to 2C-I. These results are in accordance with general findings that N-alkylation of psychedelic phenethylamines results in dramatic or complete losses of psychedelic and related activities. In contrast to simple N-alkylation however, the N-benzyl derivative of 2C-I, 25I-NB (N-benzyl-2C-I), showed similar affinity for the serotonin 5-HT2A receptor compared to 2C-I itself. Relatedly, the N-(2-methoxybenzyl) derivatives, such as 25I-NBOMe, have not only retained but greatly enhanced activity and constitute the extremely potent NBOMe family of psychedelics.
N-Methyl-2C-I was first described in the scientific literature by at least 2012. It is a controlled substance in Canada under phenethylamine blanket-ban language.
The public source identifies “N-Methyl-2C-I” as pharmaceutical compound. This brief keeps that definition visible, then builds a research path around N-Methyl-2C-I, pharmaceutical and compound.
Why this record matters
A short description can identify a subject without explaining its stakes. For “N-Methyl-2C-I”, the useful work is to connect “pharmaceutical compound” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jan 19, 2026. The linked authority identifier is Q134724720. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2012.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “N-Methyl-2C-I”, its source revision and the description used here.
- Expand the search: follow N-Methyl-2C-I primary sources, N-Methyl-2C-I archive and N-Methyl-2C-I research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “N-Methyl-2C-I”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “N-Methyl-2C-I” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.